Tinzaparin has FDA-approved labeling for use in the treatment of acute symptomatic DVT with or without PE when administered in conjunction with warfarin sodium. An advantage of tinzaparin, like all ...
Assays were linear over the range from 0.0 to 1 IU/mL for anti-Xa activity (mean r = 0.994 [n = 114], range = 0.995-1.0) and from 0 to 0.4 IU/mL for anti-IIa activity (mean r = 0.9963 [n = 71], range ...
New low concentration options in Freeflex ® IV bags join broadest portfolio of heparin sodium therapies LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results